Novo Nordisk Sues Pharmacy For Selling Compounded Drugs Containing Semaglutide
HOUSTON — Novo Nordisk Inc. on May 30 filed a complaint in a Texas federal court, asking that a pharmacy be enjoined from “selling misbranded injectable, non-FDA approved drugs that claim...To view the full article, register now.
Already a subscriber? Click here to view full article